HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis

Wael G Morsi1, Olfat G Shaker, Emad F Ismail

  • 1Department of Medical Biochemistry, Faculty of Medicine, Suez Canal University, Egypt.

Clinical Biochemistry
|September 27, 2006
PubMed

Insights

Heme oxygenase-1 (HO-1) and vascular endothelial growth factor (VEGF) are linked to atherosclerosis. HO-1 appears in advanced lesions, while VEGF increases with lesion severity, suggesting a connection in advanced atherosclerotic endothelial cells.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Atherosclerosis Research

Background:

  • Heme oxygenase-1 (HO-1) and vascular endothelial growth factor (VEGF) play roles in atherosclerosis progression.
  • Understanding their interplay in endothelial cells (ECs) is crucial for atherosclerosis research.

Purpose of the Study:

  • To investigate the relationship between HO-1 and VEGF gene expression and protein levels in human atherosclerotic arterial ECs.
  • To determine the presence and levels of HO-1 and VEGF in early and advanced atherosclerotic lesions.

Main Methods:

  • Analysis of 17 human arterial specimens with early/advanced atherosclerotic lesions and 10 healthy controls.
  • Measurement of HO-1 and VEGF expression, HO activity, and VEGF protein content in isolated ECs.

Main Results:

  • HO-1 expression and activity were detected exclusively in ECs from advanced atherosclerotic lesions.
  • VEGF expression and protein were found in early and advanced lesions, increasing with severity.
  • A significant positive correlation was observed between HO activity and VEGF protein in advanced lesions.

Conclusions:

  • HO-1 is specific to advanced atherosclerosis, while VEGF is present throughout, escalating with disease severity.
  • Findings suggest a significant association between HO activity and VEGF protein in ECs of advanced human atherosclerotic lesions.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...